| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/11/2008 | EP1930728A1 Use of the mal protein as a tumour marker |
| 06/11/2008 | EP1930721A2 Method and system for multi-stage isoelectric focussing |
| 06/11/2008 | EP1930440A1 Bacterial Strains, Genes and Enzymes for Control of Bacterial Diseases by Quenching Quorum-Sensing Signals |
| 06/11/2008 | EP1930439A1 Neurotrophic factors |
| 06/11/2008 | EP1930438A1 Transcription factor for killer cell activation, differentiation and uses thereof |
| 06/11/2008 | EP1930437A1 Gankyrin |
| 06/11/2008 | EP1930433A1 T-cell receptor and nucleic acid encoding the receptor |
| 06/11/2008 | EP1930432A1 Tryptophan transporter gene and use thereof |
| 06/11/2008 | EP1930431A1 Gene capable of enhancing low temperature fermentation ability and/or freezing stress resistance and use thereof |
| 06/11/2008 | EP1930427A1 Squamous cell carcinoma antigen-derived peptide binding to hla-a24 molecule |
| 06/11/2008 | EP1930424A1 Novel apoptosis inducing factor and method of inducing apoptosis using the same |
| 06/11/2008 | EP1930420A1 Isolated nucleic acid molecules encoding a bacterial uracil phosphoribosyl-transferase enzyme, cells transformed therewith and uses thereof |
| 06/11/2008 | EP1930418A1 Methods for generating high titer helper-free preparations of released recombinant AAV vectors |
| 06/11/2008 | EP1930409A1 L-glutamic acid-producing bacterium and method for production of l-glutamic acid |
| 06/11/2008 | EP1930345A1 Novel tumor marker |
| 06/11/2008 | EP1930344A1 Polypeptide having anti-angiogenic activity |
| 06/11/2008 | EP1930343A1 Method for preparation of reduced keratin, reduced cuticle protein or mixture thereof |
| 06/11/2008 | EP1930342A1 OB-fold used as scaffold for engineering new specific binders |
| 06/11/2008 | EP1930026A1 A method for generating birnavirus from synthetic RNA transcripts |
| 06/11/2008 | EP1930022A1 Treatment of bladder fibrosis with antibodies against alpha V beta 6 integrin |
| 06/11/2008 | EP1930021A2 Novel amide derivatives as growth hormone secretagogues |
| 06/11/2008 | EP1929860A1 Transgenic avian which has foreign gene containing sequence encoding feline-derived protein and method for production thereof |
| 06/11/2008 | EP1929311A1 Method for detecting autoimmune antibodies against tsh receptors and novel tsh-receptor chimaeras |
| 06/11/2008 | EP1929310A2 Human g protein-coupled receptor and modulators thereof for the treatment of atherosclerosis and atherosclerotic disease and for the treatment of conditions related to mcp-1 expression |
| 06/11/2008 | EP1929309A2 Method for identifying therapeutics using biomarkers responsive to thiazolidinediones |
| 06/11/2008 | EP1929303A2 Assay and kits therefor |
| 06/11/2008 | EP1929022A2 Method of using pore-forming peptides for genetic transformation, protein extraction, and transmembrane transport |
| 06/11/2008 | EP1929021A2 Adenoviral vector-based malaria vaccines |
| 06/11/2008 | EP1929005A1 Human coagulation factor vii polypeptides |
| 06/11/2008 | EP1928916A2 Immunomodulatory compositions and uses therefor |
| 06/11/2008 | EP1928915A2 An ultra-high yield intravenous immune globulin preparation |
| 06/11/2008 | EP1928909A1 Tumor angiogenesis associated genes and a method for their identification |
| 06/11/2008 | EP1928908A2 Nucleic acid molecules encoding constitutive triple response1-like polypeptides and methods of use thereof |
| 06/11/2008 | EP1928907A2 Vegf-activated fas ligands |
| 06/11/2008 | EP1928906A2 Liquid formulations of pegylated growth hormone |
| 06/11/2008 | EP1928905A2 Binding domains of proteins of the repulsive guidance molecule (rgm) protein family and functional fragments thereof, and their use |
| 06/11/2008 | EP1928904A2 Method and system for extracting blood-derived growth factors |
| 06/11/2008 | EP1928903A2 Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
| 06/11/2008 | EP1928902A2 Dekkera/brettanomyces cytosine deaminases and their use |
| 06/11/2008 | EP1928901A2 Polypeptides having beta-glucosidase activity and polynucleotides encoding same |
| 06/11/2008 | EP1928900A1 Variants of the lantibiotic mersacidin and their use |
| 06/11/2008 | EP1928899A1 An l-amino acid-producing bacterium and a method for producing an l-amino acid |
| 06/11/2008 | EP1928898A1 Fish vaccine |
| 06/11/2008 | EP1928897A2 Zinc finger binding domains for cnn |
| 06/11/2008 | EP1928896A2 Anchoring disruption molecules |
| 06/11/2008 | EP1928489A2 Analogs of ghrelin |
| 06/11/2008 | EP1928487A2 A novel peptide involved in energy homeostasis |
| 06/11/2008 | EP1928227A2 Transgenic plants with enhanced agronomic traits |
| 06/11/2008 | EP1828237A4 Human cancer suppressor gene, protein encoded therein, expression vector containing the same, and cell transformed by the vector |
| 06/11/2008 | EP1751183A4 Fas associated factor 1 |
| 06/11/2008 | EP1641930A4 Nucleic acid sequences encoding proteins associated with abiotic stress response and plant cells and plants with increased tolerance to environmental stress |
| 06/11/2008 | EP1597557A4 A method for diagnosis and prognosis of multiple sclerosis |
| 06/11/2008 | EP1581627A4 Yeast protein expression secretion system |
| 06/11/2008 | EP1558737A4 Gene families associated with cancers |
| 06/11/2008 | EP1492440B1 A new method for the diagnosis and prognosis of malignant diseases |
| 06/11/2008 | EP1443816B1 Methods of treating disorders related to apoe |
| 06/11/2008 | EP1392846B1 METHODS AND COMPOSITIONS FOR MODIFYING APOLIPOPROTEIN B mRNA EDITING |
| 06/11/2008 | EP1301637B1 Dna vaccines encoding hiv accessory proteins |
| 06/11/2008 | EP1230345B1 Environmental stress tolerance genes |
| 06/11/2008 | EP0979298B1 Metastasis models using green fluorescent protein (gfp) as a marker |
| 06/11/2008 | EP0954529B1 Porphyromonas gingivalis antigens for the diagnosis and treatment of periodontitis |
| 06/11/2008 | EP0948538B1 Analysis and separation of platelet-derived growth factor proteins |
| 06/11/2008 | EP0948522B1 Therapeutic and diagnostic agents capable of modulating cellular responsiveness to cytokines |
| 06/11/2008 | EP0891551B1 Protein phosphatase-1 catalytic subunit interactions |
| 06/11/2008 | CN101198699A Porcine circovirus and helicobacter combination vaccines and methods of use |
| 06/11/2008 | CN101198692A HIV vaccine |
| 06/11/2008 | CN101198625A Anti-IL-22RA antibodies and binding partners and methods of using in inflammation |
| 06/11/2008 | CN101198624A IL-31 monoclonal antibodies and methods of use |
| 06/11/2008 | CN101198623A Methods and compositions for modulating and detecting WISP activity |
| 06/11/2008 | CN101198622A Polypeptides and use thereof |
| 06/11/2008 | CN101198621A Molecules and chimeric molecules thereof |
| 06/11/2008 | CN101198620A Methods and compositions to elicit multivalent immune responses against dominant and subdominant epitopes, expressed on cancer cells and tumor stroma |
| 06/11/2008 | CN101198349A Use of leptin for the prevention of excess body weight and composition containing leptin |
| 06/11/2008 | CN101198343A Platelet-derived growth factor compositions and methods of use thereof |
| 06/11/2008 | CN101195658A Fluoranthene coatingen FL-OVA, production and uses thereof |
| 06/11/2008 | CN101195657A Type I cell factor receptor sample molecule, encoding gene and application thereof |
| 06/11/2008 | CN101195656A Recombined Japanese lamprey glandulae oris excreted L-250 protein anticoagulant efficacy |
| 06/11/2008 | CN101195655A Polyoxin synthesized regulate and control protein, encoding gene and application thereof |
| 06/11/2008 | CN101195025A Methods of treating disorders of the eye and surrounding tissue with thymosin beta4 (tb4) analogues, isoforms and other derivatives |
| 06/11/2008 | CN100393878C Vaccine |
| 06/11/2008 | CN100393877C Migratory locust chemoreception protein and its coding gene and the expression method of the protein |
| 06/11/2008 | CN100393876C Protein of tuberculosis in use for diagnosing tuberculosis |
| 06/11/2008 | CN100393866C Live antenuated parasite vaccine |
| 06/11/2008 | CN100393749C Antibody of EPSPS enzyme and its prepuration method and special antigen and application |
| 06/11/2008 | CN100393747C Novel albumins |
| 06/11/2008 | CN100393746C Tumour antigen protein and tumour antigen peptide |
| 06/11/2008 | CN100393745C Tumour antigen protein and tumour antigen peptide |
| 06/11/2008 | CN100393744C Paddy rice stalk extension gene, coded protein and application thereof |
| 06/11/2008 | CN100393743C SARS early diagnostic method and reagent box |
| 06/11/2008 | CN100393356C Modified cytokines for use in cancer therapy |
| 06/10/2008 | USRE40374 immunomodulators comprising interleukins, Flt-3 ligands, CD antigens, interferons, colony stimulating factors, nucleotides and proteins coded by such nucleotides, antibodies raised against such proteins, used to elicit immune responses in mammals |
| 06/10/2008 | US7386398 Hepatitis C Virus NS5B polymerase inhibitor binding pocket |
| 06/10/2008 | US7385107 Insect-resistant transgenic plants transformed with CryET33 and CryET34-encoding nucleic acids |
| 06/10/2008 | US7385103 Animal model, cells, and treatment for malignant melanoma |
| 06/10/2008 | US7385047 Isolated polypeptide and nucleic acid sequences derived from S. pneumoniae that are useful in diagnosis and therapy of pathological conditions; antibodies against the polypeptides; and methods for the production of the polypeptides; bactericides; vaccines; antibodies; target screening |
| 06/10/2008 | US7385045 Naturally-occurring variants of B7 proteins produced by alternative RNA splicing or alternative termination of full-length amino acid sequence; regulation of immune response in an animal; immunostimulants; anticarcinogenic agents, infections; antiallergens; antiinflammatory agents; veterinary medicine |
| 06/10/2008 | US7385044 Comprises nucleotide sequences coding fusion protein ligand which binds major histocompatibility complex and human leukocyte antigen for use in detection and prevention of infections, cancer andautoimmune disorders |
| 06/10/2008 | US7385037 Method for the preparation of gliadin- and glutenin-rich fractions out of gluten in an aqueous medium and in the presence of an acid |
| 06/10/2008 | US7385036 cDNA moleculae codes a polypeptide in which at position 4, Phe is replaced with Tyr, at positon 5, Ala replaced with Val, at position 25, Lysine replaced with Arg, and at 45, Glu is replace with Gln; for use in diagnosis and treatment of atherosclerosis and inflammation; antiapoptosis |
| 06/10/2008 | US7385035 Cytotoxic protein and utilization thereof |